MedPath

Assessment of Music Experiences in Navigating Depression Part 2

Not Applicable
Recruiting
Conditions
Depression
Registration Number
NCT07218055
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Brief Summary

This study is again looking at the use of music and music therapy experiences in navigating depression. The researchers will provide 11 sessions of music therapy and half will be followed by recitals at the Third Street School Music Settlement where the kids enrolled in our study will observe and interact with the performers and discuss and reflect on anxiety and performance and how sharing personal creativity affects them intra and interpersonally.

Detailed Description

The researchers will provide hourly weekly music therapy sessions and then go to the Third Street Music School and work with their kids and our kids providing insights and feedback. The researchers will test their depression (CDI) and Resilience (Connor Davidson)

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria

- Must indicate depression -or symptoms thereof by parent in writing

Exclusion Criteria

- none

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Conor-Davidson Resilience Scaleend of 6 months

The Conor-Davidson Resilience Scale 10-item (Conor \& Davidson, 2003, 2007) or CD-RISC10 is scale measuring the resilience of an individual. Each item is rated on a 5-point scale from 0 (not true at all) to 4 (True nearly all the time) with scoring from 0 to 40. The higher an individual scores, the greater their resilience. The lower an individual scores, the lower the individual's resilience.

Secondary Outcome Measures
NameTimeMethod
CDI2 or Children's Depression Inventory, Second Editionend of 6 months

The CDI2 is a self reported scale coming in two versions, CDI2 (28 items) and CDI2S (12 items). For this study, the CDI2S was chosen. Each item is rated on a 3-point scale from 0 to 2 with scoring from 0 to 24. 0 indicates no symptom, 1 indicates mild symptom, and 2 indicates definite symptom per item. The higher the total score, the stronger the indication for depression. Individuals who score from 0-12 indicate minimal to no depressive symptoms, individuals who score from 13-19 indicate mild depressive symptoms, and individuals who score 20 and above indicate moderate to severe depressive symptoms

Trial Locations

Locations (1)

Mount Sinai Union Square

🇺🇸

New York, New York, United States

Mount Sinai Union Square
🇺🇸New York, New York, United States
Joanne V Loewy, Doctorate
Contact
212 420-3484
Joanne.Loewy@mountsinai.org
Shantelena Mouzon
Contact
212 844-8387
Shantelena.Mouzon@mountsinai.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.